Caution in underrepresentation of older adults in clinical trials on COVID-19 vaccines
- PMID: 34673261
- PMCID: PMC8522486
- DOI: 10.1016/j.arr.2021.101486
Caution in underrepresentation of older adults in clinical trials on COVID-19 vaccines
Abstract
We read with great interest the article "Underrepresentation of older adults in clinical trials on COVID-19 vaccines: A systematic review" written by Nicola Veronese et al. This important work demonstrated that medications and vaccines commonly used in older adults have not been adequately evaluated. Concerning this systematic review, we shall like to mention some certain points deserved to be attended by the authors.
Keywords: COVID-19; Letter to the editor; Older adults; Vaccination.
Copyright © 2021 Elsevier B.V. All rights reserved.
Conflict of interest statement
The authors report no declarations of interest.
Comment in
-
Reply to "Caution in underrepresentation of older adults in clinical trials on COVID-19 vaccines".Ageing Res Rev. 2021 Dec;72:101490. doi: 10.1016/j.arr.2021.101490. Epub 2021 Oct 17. Ageing Res Rev. 2021. PMID: 34670153 Free PMC article. No abstract available.
Comment on
-
Underrepresentation of older adults in clinical trials on COVID-19 vaccines: A systematic review.Ageing Res Rev. 2021 Nov;71:101455. doi: 10.1016/j.arr.2021.101455. Epub 2021 Sep 3. Ageing Res Rev. 2021. PMID: 34487916 Free PMC article.
References
-
- Higgins J., Thomas, J. (2021). Cochrane Handbook for Systematic Reviews of Interventions, Version 6.2, 2021. Retrieved from 〈https://training.cochrane.org/handbook/current〉.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical